Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

First Banks Turns To Profit In Q1

First Banks, Inc. (FBSPRA: Quote), the holding company of First Bank, reported first-quarter net income attributable to the company of $6.9 million or $58.63 per share, compared to a net loss of $6.1 million or $481.41 per share last year.

Net interest income for the quarter declined to $43.8 million from $48.8 million a year ago. Net interest margin dropped to 2.86 percent from 2.90 percent in the prior-year quarter.

Non-interest income for the quarter increased to $17.2 million from $14.4 million last year.

Provision for loan losses for the latest quarter reduced to $2.0 million from $10.0 million in the comparable quarter last year.

Click here to receive FREE breaking news email alerts for First Banks Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After ending the previous session nearly flat, stocks moved mostly lower over the course of the trading day on Friday. Uncertainty about the outlook for monetary policy weighed on the markets ahead of next week's Federal Reserve meeting. Despite the ceasefire in eastern Ukraine, the U.S. Treasury Department on Friday announced a new round of sanctions against Russia for its role in the conflict. Treasury Secretary Jacob Lew determined that persons operating within Russia's defense and related materiel sector may now be subject to targeted sanctions. Business inventories in the U.S increased in line with economist estimates in the month of July, according to a report released by the Commerce Department on Friday. The Commerce Department said business inventories rose by 0.4 percent in July, matching the increase reported for June as well as the consensus estimate.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.